Page last updated: 2024-11-07

prednisone and Muscular Atrophy, Postpoliomyelitis

prednisone has been researched along with Muscular Atrophy, Postpoliomyelitis in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyer, FC1
Tiffreau, V1
Rapin, A1
Laffont, I1
Percebois-Macadré, L1
Supper, C1
Novella, JL1
Yelnik, AP1
Dinsmore, S1
Dambrosia, J1
Dalakas, MC1

Reviews

1 review available for prednisone and Muscular Atrophy, Postpoliomyelitis

ArticleYear
Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, drug therapy.
    Annals of physical and rehabilitation medicine, 2010, Volume: 53, Issue:1

    Topics: Cholinesterase Inhibitors; Glucocorticoids; Humans; Immunoglobulins; Postpoliomyelitis Syndrome; Pre

2010

Trials

1 trial available for prednisone and Muscular Atrophy, Postpoliomyelitis

ArticleYear
A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome.
    Annals of the New York Academy of Sciences, 1995, May-25, Volume: 753

    Topics: Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Muscles; Postpoliomyelitis Syndrome

1995